GMP Cell Banking Services Market Report

GMP Cell Banking Services Market Size

The worldwide GMP Cell banking services market size was valued at USD 203.00 million in 2024. The GMP Cell banking services market was worth USD 211.32 million in 2025 and is anticipated to reach nearly USD 291.44 million by 2033, with a rise in CAGR of 4.1% from 2025 to 2033.

MARKET DRIVERS

The first major key factor boosting the growth of the market is the rising prevalence of cancer. The rising prevalence of cancer is anticipated to boost market growth over the projected period. According to the data published by the U.S. Cancer Society, in March 2022, there were a total of 2.1 million new cancer cases and 620,723 deaths from cancer occurred in the U.S. The GMP cell banking services play a vital role in the development of novel cell-based therapies and personalized medicine approaches to treat cancer. Advancements in cell-based therapies have shown promising results in cancer treatment; these therapies often require the establishment of the GMP compliant cell bank to ensure the safety, quality, and consistency of therapeutic cells. Also, regenerative medicine plays an important role in cancer restoration, restoring damaged tissue after cancer treatment; GMP cell banking services are essential for the storage and distribution of cells used in regenerative medicine applications. Thus, this factor contributes to the overall growth of the market in the upcoming years.

The second major factor propelling the growth of the market is the increasing technological advancement by a key market player in the market to expand product portfolio driving the growth of the market. As the key market player is continuously investing in research and development to improve cell banking services, these technological innovations lead to more efficient and reliable GMP cell banking services, which help to attract larger customers. Advancements in automation have optimized the GMP cell banking services, and the leading key market player is widely adopting these technologies which offer competitive services and attract more customer; thus, this factor help in fueling the growth of the market.

The third major factor favoring the growth of the market is the rising demand for the technique in GMP cell banking services. The field of cell-based therapies has been rapidly advancing; this innovation in cell-based therapies often requires well-characterized and standardized cell banks to ensure safety and efficacy. As more cell-based therapies reach clinical trials, the demand for GMP cell banking services rises. Various research projects require GMP cell banking services to preserve and store valuable cell lines, and the rising research and development activities lead to development in the GMP cell banking services, thus boosting the growth of the global GMP cell banking services market.

The other key factors favoring the growth of the market include increasing inorganic growth strategies such as collaboration, product launch, technological advancement, rising research and development activities, and rising prevalence of cancer and other uncommon diseases.

MARKET RESTRAINTS

The GMP cell banking services are more relevant to treating various disease conditions even though some factors are limiting the overall growth of the market. The complexities in the production and manufacturing process, inconsistent demand for services, and the constantly evolving technology landscape are all factors hampering the growth of the global GMP cell banking services market. GMP cell banking services involve complex processes to ensure the quality, consistency, and safety of the cell line; the stringent regulatory requirements and maintaining the desired standard can be more challenging and time-consuming. Factors such as changes in the research priorities and regulatory approval affect the demand for these services; market players also constantly struggle to balance the capacity with fluctuating demand, leading to overburdening of services. The maintenance and achievement of regulatory compliance can be costly and time-consuming. Thus, failure to meet this standard can result in reputational damage and legal consequences affecting the growth. All these factors hamper the growth of the global GMP cell banking services market.

REPORT COVERAGE

MARKET SEGMENTATION

The research report on the GMP cell banking services market segmentation has been segmented based on cell type, end-user, and region.

By Cell Type Insights

Based on the cell type, the mammalian segment is anticipated to dominate the market and hold the largest market share in the global GMP cell banking services market. The rising inorganic growth strategies, including acquisition by key market players for mammalian cell culture services, fuel the growth. The mammalian cells are mostly used for the production of biopharmaceutical, including monoclonal antibodies and recombinant protein; the development of cell-based therapies require the use of mammalian cells, with the rising need for the biologics demand the GMP cell banking services; hence, this segment help fuel the growth of the global GMP cell banking services market.

The stem cell segment also shows lucrative growth in the market during the forecast period. Stem cells have unique regenerative properties. Also, the stem cell is an essential component for various cell-based therapies, and stem cells also have a vital role in cancer research and drug development. These cells are also used for drug screening and toxicity testing, and GMP cell banking services play a crucial role in the establishment of well-characterized and stable stem cell lines. Thus, this segment is anticipated to favor market growth in the upcoming year.

By End User Insights

Based on end-users, the Biopharmaceutical companies held a 44.60% market share in 2022 and are anticipated to dominate the market at the highest CAGR during the projected period. To boost the operating effectiveness and pipeline productivity, biopharmaceutical companies are important, and biopharmaceutical companies also focus on the development and production of biologics such as therapeutic protein, monoclonal antibodies, and GMP cell banking services are essential for establishing master cell banks, which also helps biopharmaceutical companies to meet the regulatory requirement by providing well-characterized and standardized cell lines for their manufacturing process thus this factor help in boosting the growth of these segment in the GMP cell banking services market.

The contract manufacturing organization segment is also expected to dominate the market at a healthy CAGR during the projected period.

REGIONAL ANALYSIS

The North American region is anticipated to dominate the market at the highest CAGR during the forecasted period. This region has developed biopharmaceutical industries, and it attracts substantial investment in the life sciences, including biotechnology, stem cell research, and regenerative medicine. The US has a favorable regulatory environment, and this region has numerous research institutions. Thus, this region is expected to dominate the global GMP cell banking services market.

Europe is the second largest region expected to dominate the market at the longest CAGR during the forecast period. This region held a 37.5% market share in 2022. Europe has a strong, thriving biotechnology sector with a rising focus on innovative research and development, Europe also has a supportive regulatory framework, Europe has a surge in investment in cell-based therapies, and European companies also actively engage in international collaboration and partnership. Thus, this region is expected to dominate the market during the forecast period.

The Asia-Pacific region shows lucrative growth in the global GMP cell banking services market and is expected to grow at the fastest CAGR during the forecast period. The Asia-Pacific region has seen significant growth in the biopharmaceutical industry. Many countries in this region, such as China, India, and Japan, have emerged as key players in biologics manufacturing and research, which drives the demand for GMP cell banking services to support biopharmaceutical development. The rising investment in biotechnology and life science, the rising prevalence of chronic diseases, and the growing focus on regenerative medicines are all factors propelling the growth of the market in the Asia-Pacific region.

The Latin American region is expected to grow at a healthy CAGR during the projected period. Major drivers driving the growth of this region include the growing biopharmaceutical industry, increasing investment in healthcare and research, and advancement in stem cell research and personalized medicine. These factors are propelling the demand for GMP cell banking services in this region and favoring market growth.

The Middle East and Africa region is also expected to dominate the global GMP cell banking services market at a significant CAGR during the projected period.

KEY MARKET PLAYERS

The Worldwide key players leading the global GMP cell banking services market are WuXi AppTec, Charles River Laboratories, Eurofins Scientific, Merck KGaA, Lonza, SGS Ltd, ViruSure, Austrianova, Goodwin Biotechnology, Paragon Bioservices and BioReliance.

RECENT MARKET DEVELOPMENTS

• In September 2022, FUJIFILM, The campus in Billingham, United Kingdom, of Diosynth Biotechnologies, a top-tier contract development and manufacturing organization (CDMO) for biologics, vaccines, and innovative medicines, stated the further development of its large-scale microbial manufacturing facility.
• In April 2022, A partnership between SGS, a U.S. contract manufacturing company, and Liveome, a Korean drug developer, was announced for the manufacturing process, development, and clinical manufacture of a targeted release formulation containing lyophilized microbial cells as well as to establish a cell bank for the process of developing and producing drugs.
• In April 23, 2022, In order to produce both clinical and commercial cell therapies, such as allogeneic T-cell and CAR T immunotherapies, FUJIFILM Corporation, a contract development and manufacturing organization (CDMO), completed the acquisition of Atara Biotherapeutics, Inc.

MARKET SEGMENTATION

The research report on the GMP cell banking services market segmentation has been segmented based on cell type, end-user, and region.

By Cell Type

• Mammalian
• Microbial
• Insect
• Yeast
• Avian
• Stem Cell Type
• Others

By End User

• Biopharmaceutical Companies
• Contract Manufacturing Organizations

By Region

• North America
• Latin America
• Europe
• Asia-Pacific
• Middle East and Africa